119 related articles for article (PubMed ID: 10836202)
1. Indirect evidence that estrogen replacement therapy stimulates nitric oxide synthase in postmenopausal women.
Piccinini F; Rovati L; Zanni A; Cagnacci A; Volpe A; Facchinetti F
Gynecol Endocrinol; 2000 Apr; 14(2):142-6. PubMed ID: 10836202
[TBL] [Abstract][Full Text] [Related]
2. Effects of estrogen replacement therapy on plasma levels of nitric oxide in postmenopausal women.
Cicinelli E; Ignarro LJ; Matteo MG; Galantino P; Schonauer LM; Falco N
Am J Obstet Gynecol; 1999 Feb; 180(2 Pt 1):334-9. PubMed ID: 9988796
[TBL] [Abstract][Full Text] [Related]
3. Short-term estradiol replacement in postmenopausal women selectively mutes somatostatin's dose-dependent inhibition of fasting growth hormone secretion.
Bray MJ; Vick TM; Shah N; Anderson SM; Rice LW; Iranmanesh A; Evans WS; Veldhuis JD
J Clin Endocrinol Metab; 2001 Jul; 86(7):3143-9. PubMed ID: 11443179
[TBL] [Abstract][Full Text] [Related]
4. Oestrogen replacement therapy lowers plasma levels of asymmetrical dimethylarginine in healthy postmenopausal women.
Teerlink T; Neele SJ; de Jong S; Netelenbos JC; Stehouwer CD
Clin Sci (Lond); 2003 Jul; 105(1):67-71. PubMed ID: 12625833
[TBL] [Abstract][Full Text] [Related]
5. [Changes of nitric oxide and endothelin plasma levels and effects of hormone replacement therapy in postmenopausal women].
Lai A; Zhang J; Ding L
Zhonghua Fu Chan Ke Za Zhi; 2000 Apr; 35(4):222-4. PubMed ID: 11776165
[TBL] [Abstract][Full Text] [Related]
6. Endothelin-1 and nitric oxide levels are related to cardiovascular risk factors but are not modified by estradiol replacement in healthy postmenopausal women. A cross-sectional and a randomized cross-over study.
Cagnacci A; Tarquini R; Perfetto F; Arangino S; Zanni AL; Cagnacci P; Facchinetti F; Volpe A
Maturitas; 2003 Feb; 44(2):117-24. PubMed ID: 12590007
[TBL] [Abstract][Full Text] [Related]
7. [The effect of estrogen replacement therapy on plasma nitric oxide levels in postmenopausal women].
Ye Y; Dai S; Zhang S
Zhonghua Fu Chan Ke Za Zhi; 1998 Jun; 33(6):340-1. PubMed ID: 10806670
[TBL] [Abstract][Full Text] [Related]
8. Transdermal 17 beta-estradiol combined with oral progestogen increases plasma levels of insulin-like growth factor-I in postmenopausal women.
Slowinska-Srzednicka J; Zgliczynski S; Jeske W; Stopinska-Gluszak U; Srzednicki M; Brzezinska A; Zgliczynski W; Sadowski Z
J Endocrinol Invest; 1992; 15(7):533-8. PubMed ID: 1280287
[TBL] [Abstract][Full Text] [Related]
9. Estradiol supplementation in postmenopausal women doubles rebound-like release of growth hormone (GH) triggered by sequential infusion and withdrawal of somatostatin: evidence that estrogen facilitates endogenous GH-releasing hormone drive.
Veldhuis JD; Anderson SM; Patrie JT; Bowers CY
J Clin Endocrinol Metab; 2004 Jan; 89(1):121-7. PubMed ID: 14715838
[TBL] [Abstract][Full Text] [Related]
10. Serum leptin concentrations in pre- and postmenopausal women on sex hormone therapy.
Bednarek-Tupikowska G; Filus A; Kuliczkowska-Płaksej J; Tupikowski K; Bohdanowicz-Pawlak A; Milewicz A
Gynecol Endocrinol; 2006 Apr; 22(4):207-12. PubMed ID: 16723307
[TBL] [Abstract][Full Text] [Related]
11. Transdermal estrogen replacement therapy decreases sympathetic activity in postmenopausal women.
Vongpatanasin W; Tuncel M; Mansour Y; Arbique D; Victor RG
Circulation; 2001 Jun; 103(24):2903-8. PubMed ID: 11413078
[TBL] [Abstract][Full Text] [Related]
12. Hyperaggregability and impaired nitric oxide production in platelets from postmenopausal women.
Mury WV; Brunini TM; Abrantes DC; Mendes IK; Campos MB; Mendes-Ribeiro AC; Matsuura C
Maturitas; 2015 Jan; 80(1):75-81. PubMed ID: 25456263
[TBL] [Abstract][Full Text] [Related]
13. Effects of alcohol ingestion on estrogens in postmenopausal women.
Ginsburg ES; Mello NK; Mendelson JH; Barbieri RL; Teoh SK; Rothman M; Gao X; Sholar JW
JAMA; 1996 Dec; 276(21):1747-51. PubMed ID: 8940324
[TBL] [Abstract][Full Text] [Related]
14. Serum estradiol concentration as measured by HPLC-RIA and bone mineral density in postmenopausal women during hormone replacement therapy.
Yasui T; Uemura H; Umino Y; Takikawa M; Kuwahara A; Saito S; Matsuzaki T; Maegawa M; Furumoto H; Miura M; Irahara M
Horm Res; 2004; 61(3):117-25. PubMed ID: 14676459
[TBL] [Abstract][Full Text] [Related]
15. Short-term effects of L-citrulline supplementation on arterial stiffness in middle-aged men.
Ochiai M; Hayashi T; Morita M; Ina K; Maeda M; Watanabe F; Morishita K
Int J Cardiol; 2012 Mar; 155(2):257-61. PubMed ID: 21067832
[TBL] [Abstract][Full Text] [Related]
16. Effects of transdermal estrogen replacement therapy on plasma levels of nitric oxide and plasma lipids in postmenopausal women.
Balci H; Altunyurt S; Acar B; Fadiloglu M; Kirkali G; Onvural B
Maturitas; 2005 Apr; 50(4):289-93. PubMed ID: 15780528
[TBL] [Abstract][Full Text] [Related]
17. Continuous versus cyclical transdermal estrogen replacement therapy in postmenopausal women: influence on climacteric symptoms, body weight and bleeding pattern.
Lübbert H; Nauert C
Maturitas; 1997 Dec; 28(2):117-25. PubMed ID: 9522319
[TBL] [Abstract][Full Text] [Related]
18. Effect of postmenopausal estrogen replacement on circulating androgens.
Casson PR; Elkind-Hirsch KE; Buster JE; Hornsby PJ; Carson SA; Snabes MC
Obstet Gynecol; 1997 Dec; 90(6):995-8. PubMed ID: 9397118
[TBL] [Abstract][Full Text] [Related]
19. Vasoactive biomarkers and oxidative stress in healthy recently postmenopausal women treated with hormone replacement therapy.
Maffei S; Mercuri A; Prontera C; Zucchelli GC; Vassalle C
Climacteric; 2006 Dec; 9(6):452-8. PubMed ID: 17085378
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic and pharmacodynamic properties of oral L-citrulline and L-arginine: impact on nitric oxide metabolism.
Schwedhelm E; Maas R; Freese R; Jung D; Lukacs Z; Jambrecina A; Spickler W; Schulze F; Böger RH
Br J Clin Pharmacol; 2008 Jan; 65(1):51-9. PubMed ID: 17662090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
